Your browser is no longer supported. Please, upgrade your browser.
Settings
OBLN [NASD]
Obalon Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.06 Insider Own- Shs Outstand7.73M Perf Week-16.78%
Market Cap30.41M Forward P/E- EPS next Y-0.27 Insider Trans- Shs Float7.47M Perf Month-19.73%
Income-15.90M PEG- EPS next Q-0.06 Inst Own39.60% Short Float5.93% Perf Quarter326.23%
Sales2.30M P/S13.22 EPS this Y74.40% Inst Trans-0.24% Short Ratio0.03 Perf Half Y311.27%
Book/sh0.77 P/B4.70 EPS next Y- ROA-97.30% Target Price- Perf Year158.57%
Cash/sh- P/C- EPS next 5Y- ROE-159.10% 52W Range0.62 - 10.77 Perf YTD141.33%
Dividend- P/FCF- EPS past 5Y4.10% ROI-147.00% 52W High-66.39% Beta-1.18
Dividend %- Quick Ratio1.80 Sales past 5Y-1.50% Gross Margin29.50% 52W Low483.87% ATR0.85
Employees34 Current Ratio1.80 Sales Q/Q- Oper. Margin- RSI (14)45.67 Volatility11.20% 12.32%
OptionableNo Debt/Eq0.00 EPS Q/Q67.00% Profit Margin- Rel Volume0.01 Prev Close3.43
ShortableYes LT Debt/Eq0.07 Earnings- Payout- Avg Volume14.04M Price3.62
Recom2.00 SMA20-16.88% SMA5011.36% SMA200143.91% Volume180,179 Change5.54%
Feb-25-19Upgrade Stifel Hold → Buy $2.50 → $3
Aug-03-18Reiterated Stifel Hold $3 → $2
Mar-01-21 05:03PM  
Feb-14-21 01:30PM  
Feb-10-21 12:02AM  
Feb-07-21 08:01AM  
Feb-02-21 10:37AM  
Jan-28-21 05:47PM  
Jan-25-21 01:19PM  
11:30AM  
Jan-24-21 11:07AM  
Jan-23-21 08:13AM  
Jan-22-21 04:46PM  
11:44AM  
11:30AM  
Jan-21-21 02:57PM  
10:00AM  
Jan-20-21 02:54PM  
Dec-07-20 10:33AM  
09:42AM  
Nov-26-20 08:14PM  
Nov-06-20 04:45PM  
Aug-13-20 07:00AM  
Jul-30-20 06:38AM  
Jun-19-20 06:15AM  
May-11-20 08:30AM  
May-08-20 08:00AM  
Apr-28-20 09:00AM  
Mar-25-20 08:44AM  
08:30AM  
Mar-18-20 07:36AM  
Mar-17-20 05:21PM  
Mar-12-20 01:48PM  
Feb-27-20 07:31AM  
Feb-20-20 08:15AM  
Feb-13-20 09:00AM  
Feb-07-20 04:15PM  
Jan-24-20 11:30AM  
Jan-13-20 01:27PM  
Dec-18-19 08:30AM  
Dec-10-19 01:27PM  
Nov-27-19 12:10AM  
Nov-14-19 09:00AM  
Nov-13-19 09:43AM  
Nov-08-19 08:25AM  
08:14AM  
07:15AM  
Nov-05-19 05:15AM  
Nov-01-19 10:30AM  
Oct-31-19 07:15AM  
Oct-25-19 10:30AM  
Oct-24-19 08:15AM  
Oct-22-19 08:15AM  
Oct-04-19 12:48PM  
Oct-03-19 10:10AM  
09:00AM  
Sep-28-19 12:42PM  
Sep-03-19 09:00AM  
Aug-05-19 09:00AM  
Aug-02-19 08:48AM  
Jul-26-19 04:00PM  
Jul-24-19 09:05AM  
08:53AM  
07:45AM  
Jul-23-19 08:30AM  
Jul-22-19 09:00AM  
Jul-16-19 08:30AM  
Jul-10-19 08:30AM  
Jun-24-19 08:30AM  
Jun-10-19 08:30AM  
Jun-04-19 11:42AM  
08:30AM  
Jun-03-19 08:57AM  
May-24-19 05:50PM  
12:50PM  
May-23-19 10:00AM  
08:30AM  
May-21-19 04:01PM  
May-17-19 05:50PM  
04:01PM  
May-02-19 10:33AM  
Apr-11-19 08:00AM  
Apr-03-19 08:30AM  
Mar-14-19 09:00AM  
Feb-27-19 09:00AM  
Feb-26-19 02:15AM  
Feb-22-19 10:05AM  
08:25AM  
08:00AM  
06:30AM  
Feb-21-19 09:38AM  
Feb-15-19 09:00AM  
Jan-03-19 08:15AM  
Jan-02-19 09:00AM  
08:45AM  
Dec-28-18 10:16AM  
07:29AM  
Dec-27-18 05:53PM  
Dec-21-18 10:45AM  
09:00AM  
Dec-20-18 11:07AM  
Dec-19-18 12:38PM  
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.